Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Kopka

Showing results (1-10 of 258) with videos related to

Pageof 26
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|November 27, 2012
Non-peptidyl (18)F-labelled PET tracers as radioindicators for the noninvasive detection of cancerStefan Wagner, Klaus Kopka
Pharmaceuticals (Basel, Switzerland)|August 1, 2019
Lutathera<sup>®</sup>: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide TherapyUte Hennrich, Klaus Kopka
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 11, 2017
Reply: PSMA Ligands for Imaging Prostate Cancer: Alternative Labeling by Complex Formation with Al<sup>18</sup>F<sup>2</sup>Frederik L Giesel, Klaus Kopka
RSC Medicinal Chemistry|December 2, 2024
Enhancing the radionuclide theranostic concept through the radiohybrid approachTobias Krönke, Klaus Kopka, Constantin Mamat
Basic Research in Cardiology|March 8, 2008
(18)F-labelled cardiac PET tracers: selected probes for the molecular imaging of transporters, receptors and proteasesKlaus Kopka, Otmar Schober, Stefan Wagner
Pharmaceuticals (Basel, Switzerland)|June 24, 2022
Development of Radiotracers for Imaging of the PD-1/PD-L1 AxisFabian Krutzek, Klaus Kopka, Sven Stadlbauer
Nuclear Medicine and Biology|May 29, 2021
The impact of barium isotopes in radiopharmacy and nuclear medicine - From past to presenceFalco Reissig, Klaus Kopka, Constantin Mamat
European Urology|September 19, 2015
Positron Emission Tomography-computed Tomography with Prostate-specific Membrane Antigen Ligands as a Promising Tool for Imaging of Prostate CancerUwe Haberkorn, Klaus Kopka, Boris Hadaschik
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 29, 2020
<sup>18</sup>F-Labeled Small-Molecule and Low-Molecular-Weight PET Tracers for the Noninvasive Detection of CancerChristopher M Waldmann, Klaus Kopka, Stefan Wagner
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|May 18, 2026
<sup>18</sup>F-Labeled Small-Molecule and Low-Molecular-Weight PET Tracers for the Noninvasive Detection of CancerChristopher M Waldmann, Klaus Kopka, Stefan Wagner
Pageof 26

Showing results (1-10 of 258) with videos related to

Sort By:
Pageof 26
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|November 27, 2012
Non-peptidyl (18)F-labelled PET tracers as radioindicators for the noninvasive detection of cancerStefan Wagner, Klaus Kopka
Pharmaceuticals (Basel, Switzerland)|August 1, 2019
Lutathera<sup>®</sup>: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide TherapyUte Hennrich, Klaus Kopka
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 11, 2017
Reply: PSMA Ligands for Imaging Prostate Cancer: Alternative Labeling by Complex Formation with Al<sup>18</sup>F<sup>2</sup>Frederik L Giesel, Klaus Kopka
RSC Medicinal Chemistry|December 2, 2024
Enhancing the radionuclide theranostic concept through the radiohybrid approachTobias Krönke, Klaus Kopka, Constantin Mamat
Basic Research in Cardiology|March 8, 2008
(18)F-labelled cardiac PET tracers: selected probes for the molecular imaging of transporters, receptors and proteasesKlaus Kopka, Otmar Schober, Stefan Wagner
Pharmaceuticals (Basel, Switzerland)|June 24, 2022
Development of Radiotracers for Imaging of the PD-1/PD-L1 AxisFabian Krutzek, Klaus Kopka, Sven Stadlbauer
Nuclear Medicine and Biology|May 29, 2021
The impact of barium isotopes in radiopharmacy and nuclear medicine - From past to presenceFalco Reissig, Klaus Kopka, Constantin Mamat
European Urology|September 19, 2015
Positron Emission Tomography-computed Tomography with Prostate-specific Membrane Antigen Ligands as a Promising Tool for Imaging of Prostate CancerUwe Haberkorn, Klaus Kopka, Boris Hadaschik
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 29, 2020
<sup>18</sup>F-Labeled Small-Molecule and Low-Molecular-Weight PET Tracers for the Noninvasive Detection of CancerChristopher M Waldmann, Klaus Kopka, Stefan Wagner
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|May 18, 2026
<sup>18</sup>F-Labeled Small-Molecule and Low-Molecular-Weight PET Tracers for the Noninvasive Detection of CancerChristopher M Waldmann, Klaus Kopka, Stefan Wagner
Pageof 26